Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Phase II Trial Now Recruiting, Investigates Microbiome as Immunotherapy Enhancer

Anaphylm™ Sublingual Epinephrine Shows Promising Results for Pediatric Anaphylaxis Treatment

Peanut Patch Treatment Continues to Help Toddlers Safely Build Tolerance Over Three Years

Peanut Sublingual Immunotherapy Shows Long-Term Benefits for Young Children

RAPT Therapeutics Launches Phase 2b Trial for Anti-IgE Therapy for Food Allergies

DBV Outlines Path to Regulatory Approval of Viaskin Peanut Patch

Nanoparticle Appears to Prevent, Treat Peanut Allergies in Mice

Hoping Needle-Free Intranasal Epinephrine will be Approved? Tell the FDA!

FDA Schedules Review of neffy®, an Intranasal Alternative to Epinephrine Auto-Injectors

Company Announces First Patient Dosing with Peanut Allergy Vaccine

Cancer Drug Shows Promise as Treatment for Food Allergies

Sublingual Epinephrine Faster to Maximum Concentration than Auto-Injector, Syringe

Peptide Shows Promise as an Allergen-Agnostic Treatment for Food Allergy

Novel Peanut Allergy Treatment Shown to be Safe, Effective, and Lasting

Bryn Shows UTULY™ Intranasal Epinephrine Absorbs Faster and is Sustained Longer...

Your School On Our Map

Put Your School on the Map